| Study Name: | Mesenchymal Stem Cell Infusion for COVID-19 Infection (NCT04444271) |
| Status: | Recruiting (Phase II) |
| Treatment: | MSC |
|
| Study Name: | Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 (NCT04416139) |
| Status: | Recruiting (Phase II) |
| Treatment: | MSC |
|
| Study Name: | Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia (NCT04713878) |
| Status: | Completed |
| Treatment: | MSC |
|
| Study Name: | Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia (NCT04429763) |
| Status: | Not yet recruiting (Phase II) |
| Treatment: | UC-MSC |
|
| Study Name: | Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome (NCT04565665) |
| Status: | Recruiting (Phase I) |
| Treatment: | MSC |
|
| Study Name: | NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 (NCT04315987) |
| Status: | Not yet recruiting (Phase II) |
| Treatment: | MSCs (NestaCell®) |
|
| Study Name: | Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 (NCT04611256) |
| Status: | Recruiting(Phase I) |
| Treatment: | MSC |
|
| Study Name: | Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 (NCT04456361) |
| Status: | Early Phase I |
| Treatment: | WJ-MSC |
|
| Study Name: | Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome (NCT04625738) |
| Status: | Not yet recruiting (Phase II) |
| Treatment: | WJ-MSC |
|
| Study Name: | Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 (NCT04252118) |
| Status: | Recruiting(Phase I) |
| Treatment: | MSCs |
|
| Study Name: | Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 (NCT04366271) |
| Status: | Recruiting (Phase II) |
| Treatment: | WJ-MSC |
|
| Study Name: | Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells (NCT04313322) |
| Status: | Recruiting(Phase I) |
| Treatment: |
|
|
| Study Name: | Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (NCT04366323) |
| Status: | Active, not recruiting (Phase II) |
| Treatment: | AT-MSC |
|
| Study Name: | Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia (NCT04753476) |
| Status: | Recruiting (Phase II) |
| Treatment: | Injection of Secretome-MSCs |
|
| Study Name: | Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients (NCT04336254) |
| Status: | Recruiting (Phase I, II) |
| Treatment: | Allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)| |
|
| Study Name: | Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19) (NCT04346368) |
| Status: | Not yet recruiting (Phase I, II) |
| Treatment: | BM-MSCs |
|
| Study Name: | Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) (NCT04288102) |
| Status: | Completed (Phase II) |
| Treatment: | UC-MSCs |
|
| Study Name: | Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia (NCT04527224) |
| Status: | Not yet recruiting (Phase I, II) |
| Treatment: | Adipose tissue-derived mesenchymal stem cells (AstroStem-V) |
|
| Study Name: | Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (NCT04629105) |
| Status: | Recruiting (Phase I) |
| Treatment: | Longeveron Mesenchymal Stem Cells (LMSCs) |
|
| Study Name: | Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19 (NCT04273646) |
| Status: | Not yet recruiting |
| Treatment: | UC-MSCs |
|
| Study Name: | Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress (NCT04728698) |
| Status: | Not yet recruiting (Phase II) |
| Treatment: | COVI-MSC |
|
| Study Name: | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 (NCT04348435) |
| Status: | Enrolling by invitation (Phase II) |
| Treatment: | HB-adMSCs |
|
| Study Name: | Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells (NCT04382547) |
| Status: | Enrolling by invitation (Phase I,II) |
| Treatment: | Allogenic pooled olfactory mucosa-derived MSC |
|
| Study Name: | Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia (NCT04339660) |
| Status: | Recruiting(Phase I,II) |
| Treatment: | UC-MSCs |
|
| Study Name: | Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS (NCT04657458) |
| Status: | Phase I |
| Treatment: | BM-MSC Derived Extracellular Vesicles Infusion Treatment |
|
| Study Name: | |
| Status: | Recruiting(Phase II,III) |
| Treatment: | Cell therapy protocol |
|
| Study Name: | Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 (NCT04428801) |
| Status: | Not yet recruiting(Phase II) |
| Treatment: | Autologous adipose-derived stem cells |
|
| Study Name: | Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients (NCT04457609) |
| Status: | Recruiting (Phase I) |
| Treatment: | Oseltamivir| UC-MSC |
|
| Study Name: | A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 (NCT04349631) |
| Status: | Active, not recruiting (Phase II) |
| Treatment: | HB-adMSCs |
|
| Study Name: | Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease (NCT04352803) |
| Status: | Not yet recruiting(Phase I) |
| Treatment: | Autologous Adipose MSC’s |
|
| Study Name: | Mesenchymal Stem Cells for the Treatment of COVID-19 (NCT04573270) |
| Status: | Completed(Phase I) |
| Treatment: | UC-MSC (PrimePro) |
|
| Study Name: | Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells (NCT04302519) |
| Status: | Not yet recruiting(Phase I) |
| Treatment: | Dental pulp MSC |
|
| Study Name: | Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 (NCT04490486) |
| Status: | Not yet recruiting(Phase I) |
| Treatment: | UCMSCs |
|
| Study Name: | Use of UC-MSCs for COVID-19 Patients (NCT04355728) |
| Status: | Completed (Phase I,II) |
| Treatment: | Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care. |
|
| Study Name: | An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (NCT04522986) |
| Status: | Not yet recruiting (Phase I) |
| Treatment: | MSC |
|
| Study Name: | Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs (NCT04461925) |
| Status: | Recruiting (Phase I,II) |
| Treatment: | Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells |
|
| Study Name: | Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 (NCT04371601) |
| Status: | Active, not recruiting (Phase I) |
| Treatment: | Oseltamivir mesenchymal stem cells |
|
| Study Name: | BAttLe Against COVID-19 Using MesenchYmal Stromal Cells (NCT04348461) |
| Status: | Not yet recruiting (Phase II) |
| Treatment: | Allogeneic and expanded adipose tissue-derived Mesenchymal stromal cells |
|
| Study Name: | Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 (NCT04362189) |
| Status: | Active, not recruiting (Phase II) |
| Treatment: | HB-adMSC |
|
| Study Name: | Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients (NCT04535856) |
| Status: | Completed(Phase I) |
| Treatment: | Allogeneic mesenchymal stem cell |
|
| Study Name: | Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus (NCT04293692) |
| Status: | Withdrawn |
| Treatment: | UC-MSCs |
|
| Study Name: | Safety and Efficacy of Intravenous Wharton’s Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19 (NCT04390152) |
| Status: | Recruiting (Phase I,II) |
| Treatment: | WJ-MSC |
|
| Study Name: | Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation (NCT04397796) |
| Status: | Recruiting(Phase I) |
| Treatment: | BM-Allo.MSC |
|
| Study Name: | A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 (NCT04780685) |
| Status: | Recruiting (Phase II) |
| Treatment: | hMSC |
|
| Study Name: | Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS (NCT04494386) |
| Status: | Recruiting (Phase I,II) |
| Treatment: | Umbilical Cord Lining Stem Cells (ULSC) |
|
| Study Name: | Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS) (NCT04377334) |
| Status: | Not yet recruiting (Phase II) |
| Treatment: | MSC |
|
| Study Name: | Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS (NCT04452097) |
| Status: | Not yet recruiting(Phase I,II) |
| Treatment: | Human umbilical cord mesenchymal stem cells |
|
| Study Name: | Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) (NCT04345601) |
| Status: | Recruiting (Phase I,II) |
| Treatment: | Mesenchymal Stromal Cells |
|
| Study Name: | Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 (NCT04390139) |
| Status: | Recruiting (Phase I,II) |
| Treatment: | Expanded MSC from Wharton Jelly (XCEL-UMC-BETA) |
|
| Study Name: | Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan (NCT04492501) |
| Status: | Completed |
| Treatment: | Convalescent Plasma|Drug: Tocilizumab|Drug: Remdesivir|MSC |
|
| Study Name: | Clinical Use of Stem Cells for the Treatment of Covid-19 (NCT04392778) |
| Status: | Recruiting(Phase I,II) |
| Treatment: | MSC Treatment |
|
| Study Name: | Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19 (NCT04467047) |
| Status: | Not yet recruiting (Phase I) |
| Treatment: | Mesenchymal Stromal Cells infusion |
|
| Study Name: | The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19 (NCT04537351) |
| Status: | Recruiting(Phase I,II) |
| Treatment: | Allogeneic mesenchymoangioblast-derived mesenchymal stem cells (MCA-derived MSCs)- (CYP-001) |
|
| Study Name: | ACT-20 in Patients With Severe COVID-19 Pneumonia (NCT04398303) |
| Status: | Not yet recruiting(Phase I,II) |
| Treatment: | Allogenic human umbilical derived mesenchymal stem cells (ACT-20-MSC), Allogenic human umbilical derived mesenchymal stem cells in conditioned media (ACT-20-CM) |
|
| Study Name: | Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) (NCT04361942) |
| Status: | Recruiting (Phase II) |
| Treatment: | Mesenchymal Stromal Cells| |
|
| Study Name: | Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19) (NCT03042143) |
| Status: | Recruiting(Phase I,II) |
| Treatment: | Human umbilical cord derived CD362 enriched MSCs |
|
| Study Name: | Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia (NCT04269525) |
| Status: | Recruiting(Phase II) |
| Treatment: | UC-MSCs |
|
| Study Name: | Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome (NCT04447833) |
| Status: | Active, not recruiting(Phase I) |
| Treatment: | Mesenchymal Stromal Stem Cells - KI-MSC-PL-205 |
|
| Study Name: | Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients (NCT04437823) |
| Status: | Recruiting(Phase II) |
| Treatment: | Intravenous Infusions of Stem Cells |
|
| Study Name: | Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia (NCT04602442) |
| Status: | Enrolling by invitation(Phase II) |
| Treatment: | Exosome inhalation (EXO 1 inhalation)| (EXO 2 inhalation) |
|
| Study Name: | Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARSCoV-2 Associated Pneumonia. (NCT04491240) |
| Status: | Completed(Phase I,II) |
| Treatment: | Exosome inhalation (EXO 1 inhalation)| (EXO 2 inhalation) |
|
| Study Name: | Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARSCoV-2-related ARDS (NCT04333368) |
| Status: | Active, not recruiting(Phase I,II) |
| Treatment: | Umbilical cord Wharton’s jelly-derived human Mesenchymal Stromal Cells| |
|
| Study Name: | MSCs in COVID-19 ARDS (NCT04371393) |
| Status: | Active, not recruiting (Phase III) |
| Treatment: | Expanded mesenchymal stromal cells derived from the bone marrow (Remestemcel-L) |
|
| Study Name: | Study of Descartes-30 in Acute Respiratory Distress Syndrome (NCT04524962) |
| Status: | Recruiting(Phase I,II) |
| Treatment: | RNA-engineered off-the-shelf allogeneic mesenchymal stem cell MSC (Descartes 30) |
|
| Study Name: | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) (NCT04466098) |
| Status: | Recruiting(Phase II) |
| Treatment: | Mesenchymal stromal cells |
|
| Study Name: | Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard (NCT04400032) |
| Status: | Recruiting(Phase I) |
| Treatment: | Mesenchymal Stromal Cells |
|
| Study Name: | A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia (NCT04276987) |
| Status: | Completed(Phase I) |
| Treatment: | MSCs-derived exosomes |
|
| Study Name: | Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions (NCT04684602) |
| Status: | Recruiting(Phase I,II) |
| Treatment: | Human umbilical chord tissue-derived MSC (PrimePro™/PrimeMSK™) |
